CRBN/AKT1
Checkout as a new customer
Creating an account has many benefits:
- See order and shipping status
- Track order history
- Check out faster
Checkout using your account
ID: ALA5169081
Type: PROTEIN-PROTEIN INTERACTION
Synonyms: 2.7.11.1 | AKT1 | PKB | PKB | PKB alpha | Protein kinase B | Protein kinase B alpha | Proto-oncogene c-Akt | RAC | RAC-alpha serine/threonine-protein kinase | RAC-PK-alpha
Organism: Homo sapiens
Species Group: Homo sapiens
Protein Target Classification: Enzyme / Kinase / Protein Kinase / AGC protein kinase group / AGC protein kinase AKT family
ALA ID | Relationship | Pref Name | Target Type |
---|---|---|---|
ALA5169068 | OVERLAPS WITH | VHL/AKT1 | PROTEIN-PROTEIN INTERACTION |
ALA4630728 | OVERLAPS WITH | Protein cereblon/Tyrosine-protein kinase SRC | PROTEIN-PROTEIN INTERACTION |
ALA4630727 | OVERLAPS WITH | Protein cereblon/Phosphodiesterase 6D | PROTEIN-PROTEIN INTERACTION |
ALA4630730 | OVERLAPS WITH | Protein cereblon/Tyrosine-protein kinase receptor FLT3 | PROTEIN-PROTEIN INTERACTION |
ALA4630729 | OVERLAPS WITH | Protein cereblon/HMG-CoA reductase | PROTEIN-PROTEIN INTERACTION |
ALA4630732 | OVERLAPS WITH | Protein cereblon/Serine/threonine-protein kinase WEE1 | PROTEIN-PROTEIN INTERACTION |
ALA5169080 | OVERLAPS WITH | CRBN/ADORA1 | PROTEIN-PROTEIN INTERACTION |
ALA4630731 | OVERLAPS WITH | Protein cereblon/Stem cell growth factor receptor | PROTEIN-PROTEIN INTERACTION |
ALA5169079 | OVERLAPS WITH | CRBN/AXL | PROTEIN-PROTEIN INTERACTION |
ALA5169082 | OVERLAPS WITH | CRBN/AKT2 | PROTEIN-PROTEIN INTERACTION |
Name | Specifications | Species reactivity | species | Application | View Details |
---|
Name:
3-(3-(3-(4-(1-Aminocyclobutyl)phenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl)phenyl)-N-(4-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)butyl)propanamide
Mol. Formula:
C47H46N10O5
M.W.:
830.95
AlogP:
5.41
Polar Surface Area:
220.32
HBA:
12
HBD:
5
#RO5 Violations:
3
#Rotatable Bonds:
14
Passes Ro3:
N
QED Weighted:
0.07
Name:
N-(3-(3-(4-(1-Aminocyclobutyl)phenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl)phenethyl)-4-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)butanamide
Mol. Formula:
C46H44N10O5
M.W.:
816.92
AlogP:
5.02
Polar Surface Area:
220.32
HBA:
12
HBD:
5
#RO5 Violations:
3
#Rotatable Bonds:
13
Passes Ro3:
N
QED Weighted:
0.08
Name:
N-(3-(3-(4-(1-Aminocyclobutyl)phenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl)phenethyl)-3-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)propanamide
Mol. Formula:
C49H50N10O7
M.W.:
891.00
AlogP:
4.66
Polar Surface Area:
238.78
HBA:
14
HBD:
5
#RO5 Violations:
2
#Rotatable Bonds:
18
Passes Ro3:
N
QED Weighted:
0.06
Name:
3-(3-(3-(4-(1-Aminocyclobutyl)phenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl)phenyl)-N-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethyl)propanamide
Mol. Formula:
C47H46N10O6
M.W.:
846.95
AlogP:
4.65
Polar Surface Area:
229.55
HBA:
13
HBD:
5
#RO5 Violations:
2
#Rotatable Bonds:
15
Passes Ro3:
N
QED Weighted:
0.07
Name:
3-(3-(3-(4-(1-aminocyclobutyl)phenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl)phenyl)-N-(7-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)heptyl)propanamide
Mol. Formula:
C50H52N10O5
M.W.:
873.03
AlogP:
6.58
Polar Surface Area:
220.32
HBA:
12
HBD:
5
#RO5 Violations:
3
#Rotatable Bonds:
17
Passes Ro3:
N
QED Weighted:
0.05
Name:
N-(3-(3-(4-(1-Aminocyclobutyl)phenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl)phenethyl)-5-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)pentanamide
Mol. Formula:
C47H46N10O5
M.W.:
830.95
AlogP:
5.41
Polar Surface Area:
220.32
HBA:
12
HBD:
5
#RO5 Violations:
3
#Rotatable Bonds:
14
Passes Ro3:
N
QED Weighted:
0.07
Name:
3-(3-(3-(4-(1-Aminocyclobutyl)phenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl)phenyl)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)propanamide
Mol. Formula:
C45H42N10O5
M.W.:
802.90
AlogP:
4.63
Polar Surface Area:
220.32
HBA:
12
HBD:
5
#RO5 Violations:
2
#Rotatable Bonds:
12
Passes Ro3:
N
QED Weighted:
0.08
Name:
N-(3-(3-(4-(1-Aminocyclobutyl)phenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl)phenethyl)-3-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)propanamide
Mol. Formula:
C47H46N10O6
M.W.:
846.95
AlogP:
4.65
Polar Surface Area:
229.55
HBA:
13
HBD:
5
#RO5 Violations:
2
#Rotatable Bonds:
15
Passes Ro3:
N
QED Weighted:
0.07
Name:
N-(3-(3-(4-(1-Aminocyclobutyl)phenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl)phenethyl)-7-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)heptanamide
Mol. Formula:
C49H50N10O5
M.W.:
859.00
AlogP:
6.19
Polar Surface Area:
220.32
HBA:
12
HBD:
5
#RO5 Violations:
3
#Rotatable Bonds:
16
Passes Ro3:
N
QED Weighted:
0.05
Name:
3-(3-(3-(4-(1-Aminocyclobutyl)phenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl)phenyl)-N-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)ethyl)propanamide
Mol. Formula:
C49H50N10O7
M.W.:
891.00
AlogP:
4.66
Polar Surface Area:
238.78
HBA:
14
HBD:
5
#RO5 Violations:
2
#Rotatable Bonds:
18
Passes Ro3:
N
QED Weighted:
0.06